FRANCE – ABL Biotechnologies, a South Korean biotechnology firm, has signed a global licensing and exclusive collaboration agreement with Sanofi to develop and commercialize a new Parkinson’s disease therapy candidate.…
Read More
FRANCE – Sanofi is terminating a long-running collaboration to develop haemoglobinopathies therapeutics based on Sangamo’s zinc finger nuclease (ZFN) genome-editing technology. Sangamo said in a regulatory filing in the United…
Read More
SWITZERLAND – Novartis and Alnylam have announced a collaboration to develop a targeted therapy to promote the regrowth of functional liver cells using Alnylam’s siRNA technology. The study will center…
Read More
SWITZERLAND – Novartis has agreed to pay up to US$1.5 billion for Gyroscope Therapeutics, a U.K.-based ocular gene therapy company, as the pharmaceutical giant seeks to acquire smaller companies with…
Read More
USA – Pfizer has announced the opening of a US$68.5 million gene therapy manufacturing facility in Durham, North Carolina, as part of a multi-yearUS$800 million plan to outfit its next-generation…
Read More
INDIA – Viatris and India’s Biocon Biologics are debating whether to further integrate their already deeply entwined biosimilar businesses into a US$10 billion standalone company, according to Moneycontrol, an Indian…
Read More
BELGIUM – Novartis is putting US$150 million into a Parkinson’s disease drug candidate that is competing with drugs in development at companies such as Roche and AstraZeneca. Novartis will pay…
Read More
NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…
Read More
SWITZERLAND – According to a German newspaper, Handelsblatt, the Swedish-based investment group EQT and the German Struengmann family are considering a joint bid for Novartis AG’s generics unit, Sandoz, for…
Read More
USA – A Boston federal judge has ruled that Sun Pharmaceutical Industries Ltd. must face a multidistrict lawsuit over its alleged scheme to corner the market for generic versions of…
Read More